NLT 98.5% HPLC.
COA,NMR,HPLC,MSDS, ROS,DMF all available.
We are offering three key services for new drug application,
a. Mature(repeatable) pilot process with independent intellectual property rights;
b. High purity sample designed for pharm companies;
c. Impurity study.
N-[(2R,3S)-2-(2,5-difluorophenyl)-3,4-dihydro-2H-pyran-3-yl]-Carbamic acid 1,1-dimethylethyl ester is a chiral pharmaceutical intermediate synthesized via asymmetric hydrogenation and carbamate protection. It features the molecular formula C16H20F2NO3 and serves as a critical building block for heterocyclic drug scaffolds.
Store under inert atmosphere at -20°C to prevent racemization. Handle with PPE due to potential sensitization risks; avoid inhalation of dust or vapors during scale-up processing.